Leadership

Ulrich Krasilnikoff is CEO of Curasight and a member of the Board. His background spans finance, private equity, engineering and executive management. He leads Curasight’s corporate strategy, financing and business development and overall company execution as CEO.

Professor Andreas Kjær is Curasight’s CSO, co-founder and a deputy chair of the Board. He is Professor at the University of Copenhagen and Chief Physician at Rigshospitalet, with research focused on molecular imaging, PET and theranostics in cancer. His academic work has led multiple tracers into first-in-human clinical use and forms the scientific foundation of Curasight’s uPAR platform.

Søren Fabricius is Chief Development Officer of Curasight and is responsible for advancing the company’s development programs through clinical execution.

Jesper J. Lange serves as Executive Advisor to the CEO and Board of Curasight, working closely with management on corporate strategy, capital markets, strategic transactions and positioning the company for its next stage of development. He supports financing and investor processes, partnerships and transaction readiness, drawing on extensive experience across life sciences, strategy, capital markets and transactions.